Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony™ System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay does not yet have regulatory clearance for the Symphony™ System, and we will need to receive regulatory authorization from the U.S. Food and Drug Administration before Symphony™ can be marketed as a diagnostic product in the United States. Bluejay’s first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from ’sample-to-result’ to help medical professionals make earlier and better triage/treatment decisions. More information is available at www.bluejaydx.com.

Current securities

1. Results of Operations and Financial ConditionNov 13, 2026
2. SCHEDULE 13G/A - filed by INTRACOASTAL CAPITAL, LLC regarding Bluejay Diagnostics, Inc.Nov 10, 2026
3. Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security Holders · Other EventsNov 4, 2026
4. Regulation FD DisclosureOct 13, 2026
5. Regulation FD DisclosureOct 6, 2026